Tolerance and crosstolerance to the suppressive effects of cocaine and morphine on lymphocyte proliferation

Pharmacology Biochemistry and Behavior

Volumn 53, Issue 1, 1996, Pages 227-234

  Bayer, Barbara M ^a   Hernandez, Monica C ^a   Ding, Xuan Z ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cocaine; Immunity; Lymphocyte; Morphine; Tolerance

Indexed keywords

COCAINE; MORPHINE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD CELL; CONTROLLED STUDY; CROSS TOLERANCE; CYTOLYSIS; DOSE TIME EFFECT RELATION; DRUG TOLERANCE; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; MALE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN LYMPHOCYTE; SUBCUTANEOUS DRUG ADMINISTRATION; THYMOCYTE;

ANIMALIA;

EID: 0029670209     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)00188-3     Document Type: Article

References (38)

1. Arora, P. K.; Fride, E.; Petitto, J.; Waggie, K.; Skolnick, P. Morphine-induced immune alterations in vivo. Cell Immunol. 126:343-353; 1990.
2. Bagasra, O.; Forman, L. Functional analysis of lymphocytes subpopulations in experimental cocaine abuse. I. Dose-dependent activation of lymphocyte subsets. Clin. Exp. Immunol. 77:289-293; 1989.
3. Bayer, B. M.; Daussin, S.; Hernandez, M.; Irvin, L. Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism. Neuropharmacology 29:369-374; 1990.
4. Bayer, B. M.; Gastonguay, M. R.; Hernandez, M. C. Distinction between the in vitro and in vivo inhibitory effects of morphine on blood lymphocyte proliferation based on agonist sensitivity and naltrexone reversibility. Immunopharmacology 23:117-124; 1992.
5. Bayer, B. M.; Mulroney, S. E.; Hernandez, M. C.; Ding, X. Z. Acute infusions of cocaine result in time- and dose-dependent effects on lymphocyte responses and corticosterone secretion in rats. Immunopharmacology 29:19-28; 1994.
6. Bruckner, J. V.; Jian, W. D.; Ho, B. T.; Levy, B. M. Histopathological evaluation of cocaine-induced skin lesions in rat. J. Cutan. Pathol. 9:83-95; 1982.
7. Carroll, K. E.; Lac, S. T.; Walker, M. J.; Kragh, R.; Newman, T. Effects of naltrexone in intravenous cocaine self-administration in rats during food satiation and deprivation. J. Pharmacol. Exp. Ther. 238:1-7; 1986.
8. Chaisson, R. E.; Bacchetti, P.; Osmond, D.; Brodie, B.; Sande, M. A.; Moss, A. R. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA 261:561-565; 1989.
9. Chiueh, C. C.; Kopin, I. J. Centrally mediated release by cocaine of endogenous epinephrine and norepinephrine from the sympathoadrenal medullary system of unanesthetized rats. J. Pharmacol. Exp. Ther. 205:148-154; 1978.
10. Di Paolo, T.; Rouillard, C.; Morissette, M.; Levesque, D.; Bedard, P. J. Endocrine and neurochemical actions of cocaine. Can. J. Physiol. Pharmacol. 67:1177-1181; 1989.
11. Donahoe, R. M.; Bueso-Ramos, C.; Donahoe, F.; Madden, J. J.; Falek, A. Mechanistic implications of the findings that opiates and other drugs of abuse moderate T-cell surface receptors and antigenic markers. Ann. NY Acad. Sci. 496:711-721; 1987.
12. Donahoe, R. M.; Falek, A.; Madden, J. J.; Nicholson, J. K. A.; Bokos, P.; Gallegos, K.; Veit, R. Effects of cocaine and other drugs of abuse on immune function. In: Friedman, H.; et al., eds. Drugs of abuse, immunity, and immunodeficiency. New York: Plenum Press; 1991:143-150.
13. Donahoe, R. M.; Madden, J. J.; Hollingsworth, F.; Shafer, D.; Falek, A. Morphine depression of T cell E-rosetting: Definition of the process. Fed. Proc. 44:95-99; 1985.
14. Donahoe, R. M.; Nicholson, J. K. A.; Madden, J. J.; Donahoe, F.; Shafer, D. A.; Gordon, D.; Bokos, P.; Falek, A. Coordinate and independent effects of heroin, cocaine, and alcohol abuse on T-cell E-rosette formation and antigenic marker expression. Clin. Immunol. Immunopathol. 41:254-264; 1986.
15. Fecho, K.; Dykstra, L. A.; Lysle, D. T. Evidence for beta adrenergic receptor involvement in the immunomodulatory effects of morphine. J. Pharmacol. Exp. Ther. 265:1079-1087; 1993.
16. Forman, L. J.; Estilow, S. Cocaine influences β-endorphins levels and release. Life Sci. 43:309-315; 1988.
17. Francesco, P. D.; Pica, F.; Marini, S.; Favalli, C.; Garaci, E. Thymosin alpha one restores murine T-cell-mediated responses inhibited by in vivo cocaine administration. Int. J. Immunopharmacol. 14:1-9; 1992.
18. Havas, H. F.; Dellaria, M.; Schiffman, G.; Geller, E. B.; Adler, M.W. Effect of cocaine on the immune response and host resistance in BALB/c mice. Int. Arch. Allergy Appl. Immunol. 83: 377-383; 1987.
19. Henry, D. J.; Greene, M. A.; White, F. J. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: Repeated administration. J. Pharmacol. Exp. Ther. 251:833-845; 1989.
20. Hernandez, M. C.; Flores, L. R.; Bayer, B. M. Immunosuppression by morphine is mediated by central pathways. J. Pharmacol. Exp. Ther. 267:1336-1341; 1993.
21. Johanson, C. E.; Fischman, M. W. The pharmacology of cocaine related to its abuse. Pharmacol. Rev. 41:3-52; 1989.
22. Kalivas, P. W.; Duffy, P.; DuMars, L. A.; Skinner, C. Behavioral and neurochemical effects of acute and daily cocaine adminstration in rats. J. Pharmacol. Exp. Ther. 245:485-492; 1988.
23. Klein, T. W.; Newton, C.; Friedman, H. Cocaine effects on cultured lymphocytes. In: Friedman, H.; et al., eds. Drugs of abuse, immunity, and immunodeficiency. New York: Plenum Press; 1991:151-158.
24. Ou, D. W.; Shen, M. L.; Luo, Y. D. Effects of cocaine on the immune system of Balb/c mice. Clin. Immunol. Immunopathol. 52:305-312; 1989.
25. Pertovaara, A.; Mecke, E.; Carlson, S. Attempted reversal of cocaine-induced antinociceptive effects with naloxone, an opioid antagonist. Eur. J. Pharmacol. 192:349-353; 1991.
26. Pilotte, N. S.; Sharpe, L. G.; Dax, E. M. Multiple, but not acute, infusions of cocaine alter the release of prolactin in male rats. Brain Res. 512:107-112; 1990.
27. Pruett, S. B.; Han, Y.; Fuchs, B. A. Morphine suppresses primary humoral immune responses by a predominantly indirect mechanism. J. Pharmacol. Exp. Ther. 262:923-928; 1992.
28. Ritz, M. C.; Cone, E. J.; Kuhar, M. J. Cocaine inhibition of ligand binding at dopamine norepinephrine and serotonin transporters: A structure-activity study. Life Sci. 46:635-645; 1990.
29. Ritz, M. C.; George, F. R. Cocaine-induced seizures and lethality appear to be associated with distinct central nervous system binding sites. J. Pharmacol. Exp. Ther. 264:1333-1343; 1993.
30. Rivier, C.; Vale, W. Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin-releasing factor (CRF)-mediated mechanism. Brain Res. 422:403-406; 1987.
31. Shavit, Y.; Lewis, J. W.; Terman, G. W.; Gale, R. P.; Liebeskind, J. C. Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity. Science 223:188-190; 1984.
32. Starec, M.; Rouveix, B.; Sinet, M.; Chau, F.; Desforges, B.; Pocidalo, J. J.; Lechat, P. Immune status and survival of opiate- and cocaine-treated mice infected with friend virus. J. Pharmacol. Exp. Ther. 259:745-750; 1991.
33. Taub, D. D.; Eisenstein, T. K.; Geller, E. B.; Adler, M. W.; Rogers, T. J. Immunomodulatory activity of μ- and k-selective opioid agonists. Proc. Natl. Acad. Sci. USA 88:360-364; 1991.
34. Tella, S. R.; Korupolu, G. R.; Schindler, C. W.; Goldberg, S. R. Pathophysiological and pharmacological mechanisms of acute cocaine toxicity in conscious rats. J. Pharmacol. Exp. Ther. 262: 936-946; 1992.
35. Van Dyke, C.; Stesin, A.; Jones, R.; Chuntharapal, A.; Seaman, W. Cocaine increases natural killer cell activity. J. Clin. Invest. 77:1387-1390; 1986.
36. Watson, E. S.; Murphy, J. C.; El Sohly, H. N.; El Sohly, M. A.; Turner, C. E. Effects of the adminstration of coca alkaloids on the primary immune responces of mice: interaction with Δ-9-tetrahydrocannabinoland ethanol. Toxicol. Appl. Pharmacol. 71: 1-13; 1983.
37. Weber, R. J.; Pert, A. The periaqueductal gray matter mediates opiate-induced immunosuppression. Science 245:188-190; 1989.
38. Weiss, S. H. Links between cocaine and retroviral infection. JAMA 261:607-609; 1989.